600351 亞寶藥業
按盤價 
6.620 +0.010 (+0.151%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.563 | 8.270 | 6.713 | 3.549 | 6.558 |
| 總資產報酬率 ROA (%) | 6.247 | 6.561 | 4.999 | 2.550 | 4.625 |
| 投入資產回報率 ROIC (%) | 7.085 | 7.544 | 5.789 | 2.926 | 5.251 | 邊際利潤分析 |
| 銷售毛利率 (%) | 52.135 | 51.681 | 57.854 | 55.875 | 61.030 |
| 營業利潤率 (%) | 14.822 | 11.167 | 7.778 | 4.545 | 7.352 |
| 息稅前利潤/營業總收入 (%) | 14.681 | 10.845 | 7.637 | 5.021 | 7.828 |
| 淨利潤/營業總收入 (%) | 11.616 | 8.336 | 6.183 | 3.848 | 6.649 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 113.121 | 100.817 | 131.986 | 142.178 | 88.166 |
| 價值變動淨收益/利潤總額(%) | 1.043 | -1.039 | -2.441 | -3.321 | 7.378 |
| 營業外收支淨額/利潤總額(%) | 0.041 | -2.686 | -3.358 | 1.671 | -0.806 | 償債能力分析 |
| 流動比率 (X) | 3.136 | 2.679 | 2.232 | 1.878 | 1.787 |
| 速動比率 (X) | 2.493 | 1.969 | 1.669 | 1.446 | 1.269 |
| 資產負債率 (%) | 17.524 | 18.314 | 22.325 | 27.219 | 27.304 |
| 帶息債務/全部投入資本 (%) | 3.961 | 4.408 | 8.602 | 14.200 | 16.253 |
| 股東權益/帶息債務 (%) | 2,371.834 | 2,119.686 | 1,036.449 | 588.042 | 500.797 |
| 股東權益/負債合計 (%) | 477.277 | 445.691 | 345.935 | 264.142 | 262.957 |
| 利息保障倍數 (X) | -99.804 | -357.870 | 68.940 | 12.603 | 14.655 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 41.414 | 42.162 | 48.282 | 56.801 | 58.155 |
| 存貨周轉天數 (天) | 118.411 | 118.605 | 130.818 | 145.597 | 170.291 |
| 備註： | 即時報價更新時間為 07/01/2026 12:40 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
